Benzalkonium Chloride Aerosol, Foam
NDC Package 49354-065-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Benzalkonium Chloride aerosols is a drug for further processing. This formulation utilizes a aerosol, foam delivery system. Marketed by Hk Kolmar Canada, Inc, this product is identified by NDC 49354-065.

Identification & Billing

NDC Package Code
49354-065-01
Package Description
1000 kg in 1 CONTAINER
Product Code
11-Digit Billing Format
49354006501

Clinical Specifications

Proprietary Name
Benzalkonium Chloride
Non-Proprietary Name
Benzalkonium Chloride
Substance Name
Benzalkonium Chloride
Dosage Form
Aerosol, Foam - A dosage form containing one or more active ingredients, surfactants, aqueous or nonaqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Hk Kolmar Canada, Inc
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
10-01-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49354-065-01 identifies a specific commercial package of 1000 kg in 1 container of Benzalkonium Chloride (UNFINISHED drug), drug for further processing labeled by Hk Kolmar Canada, Inc. This aerosol, foam is formulated for use and contains benzalkonium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hk Kolmar Canada, Inc on October 01, 2020. The current certification is valid through December 31, 2026.

How is this Hk Kolmar Canada, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49354006501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49354-065-01
11-Digit CMS (5-4-2)
49354-0065-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.